Liu JJ - Search Results

1

Changes in 18F-FDG uptake within minutes after chemotherapy in a rabbit VX2 tumor model.

Song SL, Liu JJ, Huang G, Wang ZH, Song YY, Sun XG, Chen T. Song SL, et al. Among authors: liu jj. J Nucl Med. 2008 Feb;49(2):303-9. doi: 10.2967/jnumed.107.044206. Epub 2008 Jan 16. J Nucl Med. 2008. PMID: 18199614 Free article.

2

Optimizing delayed scan time for FDG PET: comparison of the early and late delayed scan.

Chen YM, Huang G, Sun XG, Liu JJ, Chen T, Shi YP, Wan LR. Chen YM, et al. Among authors: liu jj. Nucl Med Commun. 2008 May;29(5):425-30. doi: 10.1097/MNM.0b013e3282f4d389. Nucl Med Commun. 2008. PMID: 18391725

3

Regional diffusion changes of cerebral grey matter during normal aging--a fluid-inversion prepared diffusion imaging study.

Ni JM, Chen S, Liu JJ, Huang G, Shen TZ, Chen XR. Ni JM, et al. Among authors: liu jj. Eur J Radiol. 2010 Aug;75(2):134-8. doi: 10.1016/j.ejrad.2009.04.028. Epub 2009 May 13. Eur J Radiol. 2010. PMID: 19443158

4

Comparison of the effect of positive and negative oral contrast agents on (18)F-FDG PET/CT scan.

Sun XG, Huang G, Liu JJ, Wan LR. Sun XG, et al. Among authors: liu jj. Hell J Nucl Med. 2009 May-Aug;12(2):115-8. Hell J Nucl Med. 2009. PMID: 19675862 Clinical Trial.

5

18F-FDG PET/CT-related metabolic parameters and their value in early prediction of chemotherapy response in a VX2 tumor model.

Song SL, Deng C, Wen LF, Liu JJ, Wang H, Feng D, Wong CY, Huang G. Song SL, et al. Among authors: liu jj. Nucl Med Biol. 2010 Apr;37(3):327-33. doi: 10.1016/j.nucmedbio.2009.12.002. Epub 2010 Jan 15. Nucl Med Biol. 2010. PMID: 20346872

6

¹⁸F-FDG PET/CT for the early prediction of the response rate and survival of patients with recurrent or metastatic breast cancer.

Zhang FC, Xu HY, Liu JJ, Xu YF, Chen B, Yang YJ, Yan NN, Song SL, Lin YM, Xu YC. Zhang FC, et al. Among authors: liu jj. Oncol Lett. 2018 Oct;16(4):4151-4158. doi: 10.3892/ol.2018.9151. Epub 2018 Jul 16. Oncol Lett. 2018. PMID: 30214554 Free PMC article.

7

Nuclear scaffold protein p54^nrb/NONO facilitates the hypoxia-enhanced progression of hepatocellular carcinoma.

Shen M, Zhang R, Jia W, Zhu Z, Zhao X, Zhao L, Huang G, Liu J. Shen M, et al. Oncogene. 2021 Jun;40(24):4167-4183. doi: 10.1038/s41388-021-01848-9. Epub 2021 Jun 2. Oncogene. 2021. PMID: 34079086 Free PMC article.

8

RNA-binding protein p54^nrb/NONO potentiates nuclear EGFR-mediated tumorigenesis of triple-negative breast cancer.

Shen M, Zhang R, Jia W, Zhu Z, Zhao L, Huang G, Liu J. Shen M, et al. Cell Death Dis. 2022 Jan 10;13(1):42. doi: 10.1038/s41419-021-04488-9. Cell Death Dis. 2022. PMID: 35013116 Free PMC article.

9

TNFα-induced IDH1 hyperacetylation reprograms redox homeostasis and promotes the chemotherapeutic sensitivity.

Yang H, Zhao X, Liu J, Jin M, Liu X, Yan J, Yao X, Mao X, Li N, Liang B, Xie W, Zhang K, Zhao J, Liu L, Huang G. Yang H, et al. Oncogene. 2023 Jan;42(1):35-48. doi: 10.1038/s41388-022-02528-y. Epub 2022 Nov 10. Oncogene. 2023. PMID: 36352097

10

The First-in-Human Whole-Body Dynamic Pharmacokinetics Study of Aptamer.

Ding D, Zhao H, Wei D, Yang Q, Yang C, Wang R, Chen Y, Li L, An S, Xia Q, Huang G, Liu J, Xiao Z, Tan W. Ding D, et al. Research (Wash D C). 2023 May 9;6:0126. doi: 10.34133/research.0126. eCollection 2023. Research (Wash D C). 2023. PMID: 37223462 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,380 results

Search Page

Filters